PRT-1398 EG2COMBO stec assay

Ended Purchase Order Awarded Last action

Contract number
W81K0022P0175
Awardee
Awarding agency
Obligated
$195,505

Award facts

Opportunity
  • W81K0022Q0136 Solicitation number
Contract value 100% obligated
$195,505.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
2330 Stanley Rd, Fort Sam Houston, TX 78234, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 $195,505
Original award $0

About this award

Rokabio Inc., doing business as Roka Bioscience, has been awarded a $195,505 firm fixed price purchase order by the Defense Health Agency to deliver the PRT-1398 EG2COMBO STEC assay. The contract has no set-aside designation and requires completion of the assay by September 30, 2023. Roka Bioscience will perform the contract from its location in Fort Sam Houston, Texas to support the Defense Health Agency's medical product needs. No major subcontractors were identified.

Quick answers

Who was awarded contract W81K0022P0175?

W81K0022P0175 was awarded to Rokabio Inc. by Medical Command (Department of the Army) on October 1, 2022.

How much is contract W81K0022P0175 worth?

The government has obligated $195,505 on W81K0022P0175.

Which agency awarded contract W81K0022P0175?

Medical Command (Department of the Army) awarded W81K0022P0175, with funding from Defense Health Agency (Department of Defense).

Was contract W81K0022P0175 competed?

The extent of competition for W81K0022P0175 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award